Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis

Sai V. Seetharaman, Mercedes Prudencio, Celeste Karch, Stephen P. Holloway, David R. Borchelt, P. John Hart

Research output: Contribution to journalShort survey

63 Citations (Scopus)

Abstract

Mutations in human copper-zinc superoxide dismutase (SOD1) cause an inherited form of amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease, motor neuron disease). Insoluble forms of mutant SOD1 accumulate in neural tissues of human ALS patients and in spinal cords of transgenic mice expressing these polypeptides, suggesting that SOD1-linked ALS is a protein misfolding disorder. Understanding the molecular basis for how the pathogenic mutations give rise to SOD1 folding intermediates, which may themselves be toxic, is therefore of keen interest. A critical step on the SOD1 folding pathway occurs when the copper chaperone for SOD1 (CCS) modifies the nascent SOD1 polypeptide by inserting the catalytic copper cofactor and oxidizing its intrasubunit disulfide bond. Recent studies reveal that pathogenic SOD1 proteins coming from cultured cells and from the spinal cords of transgenic mice tend to be metal-deficient and/or lacking the disulfide bond, raising the possibility that the disease-causing mutations may enhance levels of SOD1-folding intermediates by preventing or hindering CCS-mediated SOD1 maturation. This mini-review explores this hypothesis by highlighting the structural and biophysical properties of the pathogenic SOD1 mutants in the context of what is currently known about CCS structure and action. Other hypotheses as to the nature of toxicity inherent in pathogenic SOD1 proteins are not covered.

Original languageEnglish (US)
Pages (from-to)1140-1154
Number of pages15
JournalExperimental Biology and Medicine
Volume234
Issue number10
DOIs
StatePublished - Oct 2009
Externally publishedYes

Fingerprint

Superoxide Dismutase
Zinc
Copper
Amyotrophic Lateral Sclerosis
Disulfides
Mutation
Transgenic Mice
Spinal Cord
Proteostasis Deficiencies
Motor Neuron Disease
Peptides
Proteins
Poisons
Neurons
Toxicity
Cultured Cells
Metals
Cells
Amyotrophic lateral sclerosis 1
Tissue

Keywords

  • Amyloid
  • Amyotrophic lateral sclerosis
  • Motor neuron disease
  • Protein aggregation
  • Protein misfolding
  • Protofibrils
  • SOD1
  • Superoxide dismutase

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis. / Seetharaman, Sai V.; Prudencio, Mercedes; Karch, Celeste; Holloway, Stephen P.; Borchelt, David R.; Hart, P. John.

In: Experimental Biology and Medicine, Vol. 234, No. 10, 10.2009, p. 1140-1154.

Research output: Contribution to journalShort survey

Seetharaman, Sai V. ; Prudencio, Mercedes ; Karch, Celeste ; Holloway, Stephen P. ; Borchelt, David R. ; Hart, P. John. / Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis. In: Experimental Biology and Medicine. 2009 ; Vol. 234, No. 10. pp. 1140-1154.
@article{920ea0d2e38344b789071e53a5a782a8,
title = "Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis",
abstract = "Mutations in human copper-zinc superoxide dismutase (SOD1) cause an inherited form of amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease, motor neuron disease). Insoluble forms of mutant SOD1 accumulate in neural tissues of human ALS patients and in spinal cords of transgenic mice expressing these polypeptides, suggesting that SOD1-linked ALS is a protein misfolding disorder. Understanding the molecular basis for how the pathogenic mutations give rise to SOD1 folding intermediates, which may themselves be toxic, is therefore of keen interest. A critical step on the SOD1 folding pathway occurs when the copper chaperone for SOD1 (CCS) modifies the nascent SOD1 polypeptide by inserting the catalytic copper cofactor and oxidizing its intrasubunit disulfide bond. Recent studies reveal that pathogenic SOD1 proteins coming from cultured cells and from the spinal cords of transgenic mice tend to be metal-deficient and/or lacking the disulfide bond, raising the possibility that the disease-causing mutations may enhance levels of SOD1-folding intermediates by preventing or hindering CCS-mediated SOD1 maturation. This mini-review explores this hypothesis by highlighting the structural and biophysical properties of the pathogenic SOD1 mutants in the context of what is currently known about CCS structure and action. Other hypotheses as to the nature of toxicity inherent in pathogenic SOD1 proteins are not covered.",
keywords = "Amyloid, Amyotrophic lateral sclerosis, Motor neuron disease, Protein aggregation, Protein misfolding, Protofibrils, SOD1, Superoxide dismutase",
author = "Seetharaman, {Sai V.} and Mercedes Prudencio and Celeste Karch and Holloway, {Stephen P.} and Borchelt, {David R.} and Hart, {P. John}",
year = "2009",
month = "10",
doi = "10.3181/0903-MR-104",
language = "English (US)",
volume = "234",
pages = "1140--1154",
journal = "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)",
issn = "1535-3702",
publisher = "SAGE Publications Ltd",
number = "10",

}

TY - JOUR

T1 - Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis

AU - Seetharaman, Sai V.

AU - Prudencio, Mercedes

AU - Karch, Celeste

AU - Holloway, Stephen P.

AU - Borchelt, David R.

AU - Hart, P. John

PY - 2009/10

Y1 - 2009/10

N2 - Mutations in human copper-zinc superoxide dismutase (SOD1) cause an inherited form of amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease, motor neuron disease). Insoluble forms of mutant SOD1 accumulate in neural tissues of human ALS patients and in spinal cords of transgenic mice expressing these polypeptides, suggesting that SOD1-linked ALS is a protein misfolding disorder. Understanding the molecular basis for how the pathogenic mutations give rise to SOD1 folding intermediates, which may themselves be toxic, is therefore of keen interest. A critical step on the SOD1 folding pathway occurs when the copper chaperone for SOD1 (CCS) modifies the nascent SOD1 polypeptide by inserting the catalytic copper cofactor and oxidizing its intrasubunit disulfide bond. Recent studies reveal that pathogenic SOD1 proteins coming from cultured cells and from the spinal cords of transgenic mice tend to be metal-deficient and/or lacking the disulfide bond, raising the possibility that the disease-causing mutations may enhance levels of SOD1-folding intermediates by preventing or hindering CCS-mediated SOD1 maturation. This mini-review explores this hypothesis by highlighting the structural and biophysical properties of the pathogenic SOD1 mutants in the context of what is currently known about CCS structure and action. Other hypotheses as to the nature of toxicity inherent in pathogenic SOD1 proteins are not covered.

AB - Mutations in human copper-zinc superoxide dismutase (SOD1) cause an inherited form of amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease, motor neuron disease). Insoluble forms of mutant SOD1 accumulate in neural tissues of human ALS patients and in spinal cords of transgenic mice expressing these polypeptides, suggesting that SOD1-linked ALS is a protein misfolding disorder. Understanding the molecular basis for how the pathogenic mutations give rise to SOD1 folding intermediates, which may themselves be toxic, is therefore of keen interest. A critical step on the SOD1 folding pathway occurs when the copper chaperone for SOD1 (CCS) modifies the nascent SOD1 polypeptide by inserting the catalytic copper cofactor and oxidizing its intrasubunit disulfide bond. Recent studies reveal that pathogenic SOD1 proteins coming from cultured cells and from the spinal cords of transgenic mice tend to be metal-deficient and/or lacking the disulfide bond, raising the possibility that the disease-causing mutations may enhance levels of SOD1-folding intermediates by preventing or hindering CCS-mediated SOD1 maturation. This mini-review explores this hypothesis by highlighting the structural and biophysical properties of the pathogenic SOD1 mutants in the context of what is currently known about CCS structure and action. Other hypotheses as to the nature of toxicity inherent in pathogenic SOD1 proteins are not covered.

KW - Amyloid

KW - Amyotrophic lateral sclerosis

KW - Motor neuron disease

KW - Protein aggregation

KW - Protein misfolding

KW - Protofibrils

KW - SOD1

KW - Superoxide dismutase

UR - http://www.scopus.com/inward/record.url?scp=70349759885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349759885&partnerID=8YFLogxK

U2 - 10.3181/0903-MR-104

DO - 10.3181/0903-MR-104

M3 - Short survey

C2 - 19596823

AN - SCOPUS:70349759885

VL - 234

SP - 1140

EP - 1154

JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

SN - 1535-3702

IS - 10

ER -